Trials in New York, New York
Here are the top 10 medical studies for colorectal cancer in New York, New York
Popular Filters
Phase 3 Trials
Chemotherapy
Pump Chemotherapy for Colorectal Cancer
Recruiting2 awardsPhase 3
Montvale, New Jersey
"This trial is comparing using a special pump to deliver chemotherapy directly to the liver along with regular chemotherapy versus regular chemotherapy alone for patients with colorectal cancer that has spread to the liver and cannot be removed by
PD-1 Inhibitor
Dostarlimab for Colon Cancer
Recruiting2 awardsPhase 3
Bronx, New York
This trial is testing dostarlimab, a drug that helps the immune system fight cancer. It targets patients with a specific type of colon cancer that has certain genetic features and can be surgically removed. Dostarlimab works by helping the immune system recognize and destroy cancer cells.
Monoclonal Antibodies
ABBV-400 vs Standard Treatment for Colorectal Cancer
Recruiting2 awardsPhase 3
New Brunswick, New Jersey
This trial aims to compare the effectiveness and safety of the investigational drug ABBV-400 with the standard treatment for metastatic colorectal cancer. Participants will receive either ABBV-400 or
Monoclonal Antibodies
Amivantamab + Chemotherapy vs Cetuximab + Chemotherapy for Colorectal Cancer
Recruiting2 awardsPhase 3
New Brunswick, New Jersey
This trial aims to see how long patients with a specific type of colorectal cancer can remain free of the disease when treated with two different drug combinations.
Trials With No Placebo
Monoclonal Antibodies
Combination Immunotherapy for Colorectal Cancer
Recruiting1 awardPhase 2
New York, New York
This trial is testing two special drugs that help the immune system fight a specific type of cancer. The drugs are given to see if they can shrink the cancer. The study focuses on patients who might not respond well to other treatments. The goal is to see if these drugs are safe and effective.
Chemotherapy
KFA115 + Tislelizumab for Advanced Cancers
Recruiting1 awardPhase 1
New York, New York
This trial tests a new drug, KFA115, alone and with pembrolizumab in patients with advanced cancers. It aims to find the safest dose and see if the drugs can reduce tumors. The focus is on patients whose cancers are hard to treat with current options.
Chemotherapy
PF-07799544 for Cancer
Recruiting1 awardPhase 1
Montvale, New Jersey
This trial tests a new cancer medicine, PF-07799544, taken regularly as a tablet. It is for people with advanced solid tumors who haven't responded to other treatments. The medicine may be used alone or with other drugs to improve its effectiveness.
Antibody-Drug Conjugate
Dato-DXd Combination Therapy for Advanced Cancers
Recruiting1 awardPhase 2
Commack, New York
This trial is testing Dato-DXd, a targeted cancer treatment, in patients with advanced or metastatic solid tumors. The treatment aims to deliver chemotherapy directly to cancer cells, helping to kill them while reducing harm to healthy cells.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.